This consensus document provides a comprehensive review of sex differences in the clinical evaluation, treatment, and outcomes of cardiac arrhythmias.
Sex differences warrant tailored arrhythmia management; extends male-predominant evidence by synthesizing sex-specific evaluation and outcomes.
Cardiac arrhythmias comprise a heterogenous group of disorders ranging from benign premature heart beats to malignant sustained ventricular tachyarrhythmias. Catheter and device-based therapies coupled with landmark clinical trials have enhanced our understanding and treatment of these disorders. Studies evaluating pathophysiology, disease course, and therapeutic options for cardiac arrhythmias have been performed in predominantly male patients. Sex differences have the potential to impact diagnostic and therapeutic interventions in a wide variety of medical conditions and cardiac arrhythmias are no exception. This chapter will review sex differences in different cardiac arrhythmias with an emphasis on clinical evaluation, treatment, and outcomes.
No takes yet. Share an insight, caveat, or question.
Linde et al. (2018) conducted a review in Cardiac arrhythmias. Sex differences was evaluated. This consensus document reviews sex differences in the clinical evaluation, treatment, and outcomes of various cardiac arrhythmias, noting that most prior studies predominantly evaluated male patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: